Osteopore Collaborates to Develop New Products

By Julie A. Vetalice

Osteopore Collaborates to Develop New Products

Osteopore signed a collaboration agreement with Livingstone Health to jointly develop new applications and products for regenerating bone and tissue.

Livingstone Health is a Singapore-based multidisciplinary healthcare group. Under the agreement, Livingstone surgeons will work with Osteopore to jointly develop products, solutions and therapies for bone and tissue regeneration using Osteopore’s bioresorbable implants.

Osteopore’s implants dissolve over time to leave only natural bone, and have outperformed traditional implant methods in terms of design, post-surgery complications and associated long-term healthcare costs.

Surgeons will apply new and existing Osteopore implants in a clinical
setting for orthopedic procedures. The first, Osteomesh® rigid but flexible
bioresorbable scaffold, will be used for tendon repair including rotator cuff and
Achilles tendon. To date, Osteomesh has been used in cranial and orbital reconstruction, as well as in rhinoplasty, as a cartilage support. The partnership with
Livingstone will enable the expansion of Osteomesh in tendon repair, and this
will be the first time the products are used for orthopedic applications in Singapore.

The second is an entirely new Osteopore product, a synthetic fibular strut graft, which will be used for bone reconstruction in the upper and lower limbs. The synthetic fibular strut will reduce the need to harvest bone from the fibula, avoiding additional procedures and associated complications.

Both of these procedures form part of Osteopore’s strategy to not only develop new
products, but also uncover new potential applications using its existing commercially
available implants. This is expected to provide Osteopore with patient data to further support regulatory clearances, market adoption and penetration in Singapore and beyond.

Source: Osteopore

Product Labels: Traditional Soft Tissue Repair